PSC
EW icon

Piper Sandler & Co’s Edwards Lifesciences EW Stock Holding History

Piper Sandler & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,000
Closed -$640K – 45
2015
Q3 		$640K Buy
+27,000
New +$652K 0.68% 12

Other funds holding EW

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Piper Sandler & Co's EW Position: Q4 2015 in Review

Piper Sandler & Co sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 27,000 shares — an estimated $640K sold.

Piper Sandler & Co first reported a position in EW in Q3 2015 and held it in 1 quarter. The position peaked at $640K in Q3 2015. 604 funds tracked by Wall St. Rank hold EW as of Q4 2015.

  • Piper Sandler & Co reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 27,000 Edwards Lifesciences shares in Q4 2015, an estimated $640K.
  • Piper Sandler & Co first reported a position in Edwards Lifesciences in Q3 2015 and held it in 1 quarter.
  • Piper Sandler & Co's Edwards Lifesciences position peaked at $640K in Q3 2015.
  • 604 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.